NCT02772003 2026-03-18
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
60 trialsNCT03520660 2026-03-11
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06842563 2025-07-09
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Singlera Genomics Inc.
Active not recruiting
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT06745895 2024-12-20
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Recruiting
NCT06718530 2024-12-05
VERYMARKERS
Centro di Riferimento Oncologico - Aviano
Recruiting
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT05181826 2024-06-14
ELITE
Helio Genomics
Unknown
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT05498779 2023-11-28
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT03903185 2023-08-22
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
Ain Shams University
Phase 1/2 Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT04980157 2023-01-23
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT00375011 2022-12-20
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Meridian Bioscience, Inc.
Terminated
NCT03944447 2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2 Unknown
NCT04190498 2022-05-24
ECHAPS
University Hospital, Grenoble
Withdrawn
NCT05376943 2022-05-17
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Unknown
NCT05067374 2022-04-08
Mammo'C
University Hospital, Montpellier
Unknown
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT03200171 2021-07-21
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Completed
NCT03707080 2021-07-06
Direct Acting Antiviral-Post Authorization Safety Study
Target PharmaSolutions, Inc.
Completed
NCT03254121 2021-02-18
HEPCASUS
Karolinska Institutet
Completed
NCT04090164 2020-10-19
Association of Hepatitis C Virus With Breast Cancer
Mansoura University
Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT04546802 2020-09-14
HATCHeT
Bayside Health
Phase 3 Withdrawn
NCT04395118 2020-07-02
STOP-HCC
University of Texas Southwestern Medical Center
Phase NA Withdrawn
NCT02868242 2020-03-02
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Phase 2 Completed
NCT00341705 2019-12-17
The Second Multicenter Hemophilia Cohort Study
National Institutes of Health Clinical Center (CC)
Completed
NCT00825877 2019-12-17
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
Completed
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT03775798 2018-12-19
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Unknown
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT03261349 2017-08-25
Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
National Taiwan University Hospital
Phase 2 Unknown
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated
NCT00897312 2016-04-25
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Vanderbilt-Ingram Cancer Center
Terminated
NCT02588560 2015-10-28
Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy
Chang Gung Memorial Hospital
Unknown